Cargando…
A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block CTLA-4, PD-1, or PD-L1 and induce the activation of the immune system against cancer. Despite the efficacy of ICIs, which has improved the oncotherapy for patients with a variety of malignancies, several immune-related adverse...
Autores principales: | Rubio-Infante, Nestor, Ramírez-Flores, Yoel Adbel, Castillo, Elena Cristina, Lozano, Omar, García-Rivas, Gerardo, Torre-Amione, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006991/ https://www.ncbi.nlm.nih.gov/pubmed/35433707 http://dx.doi.org/10.3389/fcell.2022.851032 |
Ejemplares similares
-
Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
por: Ma, Wanjun, et al.
Publicado: (2020) -
Mitochondrial and Sarcoplasmic Reticulum Interconnection in Cardiac Arrhythmia
por: Salazar-Ramírez, Felipe, et al.
Publicado: (2021) -
Soluble factors in COVID-19 mRNA vaccine-induced myocarditis causes cardiomyoblast hypertrophy and cell injury: a case report
por: Paredes-Vazquez, Jose Gildardo, et al.
Publicado: (2023) -
Temporal Frame of Immune Cell Infiltration during Heart Failure Establishment: Lessons from Animal Models
por: Brenes-Castro, David, et al.
Publicado: (2018) -
What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?
por: Castillo, Elena C., et al.
Publicado: (2020)